drugset / Trial / NCT00407433

Clinical Studies of Gemcitabine-Oxaliplatin

NCT00407433 ↗

Phase 2 Completed 156 enrolled Gustave Roussy, Cancer Campus, Grand Paris
Non-randomizedSingle-groupOpen-labelTreatment

Summary

These are Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory or relapsing pediatric solid tumors.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule — —
Subject Oxaliplatin Small molecule — —